This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Alex Gorsky, Chairman And CEO Of Johnson & Johnson And Steve Hemsley, President And CEO Of UnitedHealth Group (Photo: Piper Jaffray)

Stocks in this article: PJC

Piper Jaffray (NYSE: PJC), a leading investment bank and asset management firm, announced that its annual Heartland Summit event is underway, drawing a select group of 175 top executives, investors and physicians from across the healthcare spectrum. Featuring a unique panel-only format, industry leaders gather for two days for candid discussions on major areas of growth, opportunity and controversy in medical technology, therapeutics and healthcare services & information technology.

Alex Gorsky, Chairman and CEO of Johnson & Johnson and Steve Hemsley, President and CEO of UnitedHea ...

Alex Gorsky, Chairman and CEO of Johnson & Johnson and Steve Hemsley, President and CEO of UnitedHealth Group (Photo: Piper Jaffray)

The Piper Jaffray Heartland Summit kicked off today in Minneapolis with a “State of the Industry” CEO Panel featuring leaders from some of the world’s largest healthcare organizations. Neal Patterson of Cerner Corporation, Alex Gorsky of Johnson & Johnson, George Halverson of Kaiser Permanente, Omar Ishrak of Medtronic, Inc. and Steve Hemsley of UnitedHealth Group shared their views on innovation, market opportunities, controversies, acquisition strategies and regulatory challenges impacting their businesses.

The CEO panel was followed by a keynote address from Mike Leavitt, former Governor of Utah and the 20th Secretary of the U.S. Department of Health and Human Services. Leavitt shared his inside perspective on the role of government in the healthcare sector, and spoke about his current efforts implementing the Patient Protection and Affordable Care Act.

Afternoon panels featured topics in healthcare information technology and biotechnology, showcasing leaders from Array Biopharma Inc., Cerner Corporation, Endocyte, Inc., GNS Healthcare, Inc., Infinity Pharmaceuticals and Optum.

A Chief Medical Officer Panel concluded the day’s presentations with CMOs from Covidien, St. Jude Medical Inc. and UnitedHealth Group discussing economic and clinical hurdles, market product strategies and evolving global regulatory environments.

“This event brings together some of the industry’s most influential leaders and organizations in a very intimate format where important themes are addressed and valuable ideas are formed,” commented Piper Jaffray senior healthcare research analyst Brooks West. “With Minnesota being a hub for the medical community, we are uniquely positioned to host such an event.”

Day two of the Piper Jaffray Heartland Summit will consist of panel discussions on major therapeutic opportunities for device therapies in peripheral disease. The Peripheral Vascular Disease (PVD) Panel and Hypertension Panel will combine healthcare executives and physicians from across the U.S. to discuss opportunities in these markets. Panel participants will include executives from Boston Scientific Corporation, Covidien, C. R. Bard, Endologix Inc., Medtronic, Inc.St. Jude Medical Inc., The Spectranetics Corporation, UnitedHealth Group and Volcano Corporation.

About Piper Jaffray

Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Our proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich.

Since 1895. Member SIPC and NYSE. © 2013 Piper Jaffray Companies, 800 Nicollet Mall, Suite 800, Minneapolis, Minnesota 55402-7020

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs